Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Goldenberg

Showing results (681-690 of 968) with videos related to

Pageof 97
Sort By:
Arthritis Research & Therapy|July 25, 2006
Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II studySerge D Steinfeld, Laure Tant, Gerd R Burmester, et al.
Cancer Research|May 1, 1990
Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humansR M Sharkey, D M Goldenberg, H Goldenberg, et al.
British Journal of Haematology|July 9, 2013
Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I studyHoward A Liebman, Mansoor N Saleh, James B Bussel, et al.
Cancer|August 18, 2012
PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinomaDavid V Gold, Jochen Gaedcke, B Michael Ghadimi, et al.
Critical Reviews in Oncology/Hematology|June 22, 2001
Successful therapy of a human lung cancer xenograft using MAb RS7 labeled with residualizing radioiodineR Stein, S V Govindan, S Chen, et al.
Haematologica|August 13, 2016
Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopeniaHoward A Liebman, Mansoor N Saleh, James B Bussel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2003
Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugateGary L Griffiths, M Jules Mattes, Rhona Stein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2001
Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: evaluation of (177)Lu and comparison of its efficacy with that of (90)Y and residualizing (131)IR Stein, S V Govindan, S Chen, et al.
Molecular Cancer Therapeutics|November 15, 2017
IMMU-140, a Novel SN-38 Antibody-Drug Conjugate Targeting HLA-DR, Mediates Dual Cytotoxic Effects in Hematologic Cancers and Malignant MelanomaThomas M Cardillo, Serengulam V Govindan, Maria B Zalath, et al.
Molecular Immunology|June 1, 1992
Microheterogeneity of a purified IgG1 due to asymmetric Fab glycosylationR C Grebenau, D M Goldenberg, C H Chang, et al.
Pageof 97

Showing results (681-690 of 968) with videos related to

Sort By:
Pageof 97
Arthritis Research & Therapy|July 25, 2006
Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II studySerge D Steinfeld, Laure Tant, Gerd R Burmester, et al.
Cancer Research|May 1, 1990
Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humansR M Sharkey, D M Goldenberg, H Goldenberg, et al.
British Journal of Haematology|July 9, 2013
Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I studyHoward A Liebman, Mansoor N Saleh, James B Bussel, et al.
Cancer|August 18, 2012
PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinomaDavid V Gold, Jochen Gaedcke, B Michael Ghadimi, et al.
Critical Reviews in Oncology/Hematology|June 22, 2001
Successful therapy of a human lung cancer xenograft using MAb RS7 labeled with residualizing radioiodineR Stein, S V Govindan, S Chen, et al.
Haematologica|August 13, 2016
Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopeniaHoward A Liebman, Mansoor N Saleh, James B Bussel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2003
Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugateGary L Griffiths, M Jules Mattes, Rhona Stein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2001
Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: evaluation of (177)Lu and comparison of its efficacy with that of (90)Y and residualizing (131)IR Stein, S V Govindan, S Chen, et al.
Molecular Cancer Therapeutics|November 15, 2017
IMMU-140, a Novel SN-38 Antibody-Drug Conjugate Targeting HLA-DR, Mediates Dual Cytotoxic Effects in Hematologic Cancers and Malignant MelanomaThomas M Cardillo, Serengulam V Govindan, Maria B Zalath, et al.
Molecular Immunology|June 1, 1992
Microheterogeneity of a purified IgG1 due to asymmetric Fab glycosylationR C Grebenau, D M Goldenberg, C H Chang, et al.
Pageof 97